Project Grant R25AI183323
Award Date
7/19/24
Completion Date
6/30/29
Dollars Obligated
$379K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $781,367 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Weill Medical College of Cornell University. The grant, awarded on January 25, 2024, will support research to define and maximize the impact of CD8+ T-cell selection on the landscape of HIV integration sites. The goal is to optimize strategies for eradicating the persistent reservoir of HIV-infected cells and achieve...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $402,731 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Washington. This 5-year grant, which runs from March 1, 2025 to February 28, 2030, aims to increase the number of physician-scientists specializing in reproductive, maternal, and child health by providing training in immunology and infectious disease research. The key objectives of the grant are to: 1)...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $379,080 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Western University of Health Sciences to support a research education program focused on promoting diversity in immunologic and allergic disease research. The program will recruit 15 qualified, research-oriented participants per year from the university's health professional student population, providing them with a 2.5-month...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $212,169 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University. The grant supports research focused on advancing the PI's expertise in mentoring trainees in antimicrobial resistance (AMR) research. Specifically, the PI plans to expand their knowledge of molecular mechanisms of resistance, incorporating site-directed mutagenesis and pharmacodynamic...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $938,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Yale University. The grant, titled "Identification of Novel Regulators for Neutrophil Development and Lifespan," aims to conduct a comprehensive genetic screen to identify new mechanisms that regulate neutrophil development and lifespan. The research will leverage immortalized mouse hematopoietic progenitor...
This $693,465 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a research project to map the development of T cell immunity in lymph nodes from infancy to adulthood. The key objectives are to: 1) Determine how the spatial organization of T cells changes in the lymph node throughout childhood; 2) Examine how the lymph node shapes the CD8+ T cell response to infection in...
This $784,217 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to characterize how cellular death programs contribute to both protective and injurious inflammation during bacterial infections. The award recipient, the Research Foundation of the City University of New York (RFCUNY) - Lehman College, will utilize human cells, murine genetics, and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $300,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Topaz Biosciences, Inc., a woman-owned small business located in Emeryville, California. The funding will support the company's research to discover and optimize novel endolysins that can selectively target Gardnerella vaginalis, a key bacterial species associated with bacterial vaginosis (BV). The project aims to expand...
This federal Project Grant award, with ID R03AI182671, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award, totaling $178,932.00, supports research to analyze cord blood Vδ2 T cell differentiation and function using advanced single-cell sequencing techniques, including CITE-seq and ATAC-seq. The research aims to improve understanding of Vδ2 T cell development and potential for...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $243,361 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to Rush University Medical Center in Chicago, Illinois. The grant will support a project to establish workflows for rapid and inexpensive whole genome sequencing (WGS) of Neisseria gonorrhoeae (NG) directly from urine, throat, and rectal clinical specimens. The goal is to enhance surveillance for emerging strains of NG with reduced...